Yes, plasma from recovered patients also looks very promising. But at this stage we don't have nearly enough plasma from recovered patients to go around*, even though one person's plasma can treat three people.
(*At least not that we know of. We may find a lot more recovered patients out there if we were to start widespread testing.)
So our best bet in the immediate term is to keep trialing ALL promising treatments as expeditiously as possible.
If there turn out to be several effective treatment options, that's even better. That way there are fewer supply bottlenecks and additional treatment options for patients who can't tolerate a certain drug.
Yes, plasma from recovered patients also looks very promising. But at this stage we don't have nearly enough plasma from recovered patients to go around*, even though one person's plasma can treat three people.
(*At least not that we know of. We may find a lot more recovered patients out there if we were to start widespread testing.)
So our best bet in the immediate term is to keep trialing ALL promising treatments as expeditiously as possible.
If there turn out to be several effective treatment options, that's even better. That way there are fewer supply bottlenecks and additional treatment options for patients who can't tolerate a certain drug.